SCHEMBL24012283

SCHEMBL24012283

CO[C@]1(c2ccccc2)C[C@H](C(=O)Nc2cc(C(N)(CCC3CC3)c3ccccn3)ccc2F)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 20/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24011969 0.91 KLKB1 (0.64) KLKB1
SCHEMBL24012229 0.91 KLKB1 (0.64) KLKB1
SCHEMBL21726685 0.89 KLKB1 (0.63) KLKB1
SCHEMBL20584313 0.88 KLKB1 (0.86) KLKB1
SCHEMBL29581206 0.88 KLKB1 (0.86) KLKB1
SCHEMBL24012270 0.87 KLKB1 (0.59) KLKB1
SCHEMBL20584380 0.87 KLKB1 (0.60) KLKB1
SCHEMBL21726675 0.87 KLKB1 (0.61) KLKB1
SCHEMBL20446637 0.87 KLKB1 (0.61) KLKB1
SCHEMBL28721887 0.87 KLKB1 (0.61) KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4019022-A1 HUMAN PLASMA KALLIKREIN INHIBITORS BioCryst Pharmaceuticals, Inc. (US) 2022-06-29 — — EP disclosed
EP-3355890-B1 HUMAN PLASMA KALLIKREIN INHIBITORS BIOCRYST PHARM INC (US) 2021-11-10 — — EP disclosed
Send feedback